Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Reply to letter to the editor: "JC viremia and multiple sclerosis" by Focosi et al.
Change of fate commitment in adult neural progenitor cells subjected to chronic inflammation.
Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
Erratum.
MS Patients Report Excellent Compliance with Oral Prednisone for Acute Relapses.
Consequences of NMO-IgG binding to aquaporin-4 in neuromyelitis optica.
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica: Implication for Cellular Immune Responses.
Multiple sclerosis lesion formation and early evolution revisited: A weekly high-resolution magnetic resonance imaging study.
Neuroimaging-evident lesional pathology associated with REM sleep behavior disorder.
Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: Suppression by curcumin.
The induction of Treg cells by gut-indigenous Clostridium.
Multiple sclerosis impairs regional functional connectivity in the cerebellum.
Vitamin D in health and disease: a literature review.
[Change of treatment in patients with multiple sclerosis and its consequences in clinical practice].
Generation and characterization of a novel recombinant antibody against 15-ketocholestane isolated by phage-display.
Robot Training of Upper Limb in Multiple Sclerosis: Comparing Protocols With or WithoutManipulative Task Components.
Neuropsychiatric symptoms as a manifestation of multiple sclerosis after 2-year follow-up period.
Does hippotherapy effect use of sensory information for balance in people with multiple sclerosis?
Cortical excitability changes over time in progressive multiple sclerosis.
Long-Term Data of Efficacy, Safety and Tolerability in a Real Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients.
[Neuromyelitis optica and anti-aquaporin 4 antibody].
Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study.
The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude.
Dendritic cells and multiple sclerosis: disease, tolerance and therapy.
Pages
« first
‹ previous
…
212
213
214
215
216
217
218
219
220
…
next ›
last »